Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
birelentinib (DZD8586)
i
Other names:
DZD8586, DZD-8586, DZD 8586
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Dizal Pharma
Drug class:
BTK inhibitor, LYN inhibitor
Related drugs:
‹
ibrutinib (186)
zanubrutinib (55)
acalabrutinib (42)
orelabrutinib (23)
pirtobrutinib (14)
TG-1701 (7)
CG-806 (6)
TL895 (4)
sunvozertinib (3)
JNJ-4681 (2)
abivertinib (1)
SRX3262 (1)
SNS-062 (1)
DTRM-555 (0)
DTRMWXHS-12 (0)
GB5121 (0)
HMPL-760 (0)
HZ-A-018 (0)
KIN-8194 (0)
NRX0492 (0)
RN486 (0)
TT-01488 (0)
tirabrutinib (0)
AS-1763 (0)
RG7845 (0)
MK-1026 (0)
HM71224 (0)
LP-168 (0)
CC-292 (0)
SKLB-1028 (0)
ibrutinib (186)
zanubrutinib (55)
acalabrutinib (42)
orelabrutinib (23)
pirtobrutinib (14)
TG-1701 (7)
CG-806 (6)
TL895 (4)
sunvozertinib (3)
JNJ-4681 (2)
abivertinib (1)
SRX3262 (1)
SNS-062 (1)
DTRM-555 (0)
DTRMWXHS-12 (0)
GB5121 (0)
HMPL-760 (0)
HZ-A-018 (0)
KIN-8194 (0)
NRX0492 (0)
RN486 (0)
TT-01488 (0)
tirabrutinib (0)
AS-1763 (0)
RG7845 (0)
MK-1026 (0)
HM71224 (0)
LP-168 (0)
CC-292 (0)
SKLB-1028 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.